Christoph Brackmann

Christoph Brackmann is a seasoned finance leader with a strong focus on commercial aspects and driving change within multinational organizations.

With a background encompassing commercial and corporate finance, investor relations, corporate strategy, and expertise in M&A, FP&A, shared service centers, and team turnarounds, Christoph has excelled in fast-paced environments.

In his recent role at Shire, Christoph served as the head of global investor relations and Chief of Staff to the CFO, showcasing his expertise in organizational change and post-merger integration.

Throughout his career, which includes international experience across Europe and the US, Christoph has honed his skills in business partnering, growth strategies, and financial insights.

Noteworthy achievements in Christoph's career include instrumental roles in M&A activities like the divestment of Novartis Animal Health to Eli Lilly and the acquisition of Baxalta by Shire, along with successful team and function turnarounds.

Passionate about leadership development and cultivating productive work cultures, Christoph excels in identifying and nurturing high-potential talent.

His specialties lie in leading business-focused finance teams, M&A negotiations, finance integration, investor relations, business partnering, finance transformation, and talent development.

Christoph Brackmann holds an MBA from London Business School, Sda Bocconi, and has also completed executive education at Harvard Business School.

Currently, Christoph serves as the SVP Finance at Moderna, further showcasing his extensive experience and expertise in the finance domain.